UHC2030
UHC2030 is a global movement that aims to strengthen the global health system and accelerate progress towards universal health coverage (UHC). It was established in 2016 as a successor to the International Health Partnership (IHP+), and is co-convened by the World Health Organization (WHO) and the World Bank.
Overview[edit]
UHC2030 provides a multi-stakeholder platform that promotes collaborative working in countries and globally on health systems strengthening (HSS). It advocates for increased political commitment to UHC and facilitates accountability and knowledge sharing.
Objectives[edit]
The main objectives of UHC2030 are to:
- Promote and sustain political commitment for universal health coverage
- Facilitate multi-stakeholder dialogue and promote collaboration on health systems strengthening at all levels
- Monitor progress and promote mutual accountability
- Share knowledge and learning across countries and constituencies
Partners[edit]
UHC2030 partners include countries, bilateral and multilateral agencies, civil society organizations, private sector entities, and academic and research institutions. Key partners include the World Health Organization, the World Bank, Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Bill & Melinda Gates Foundation.
UHC2030 Framework[edit]
The UHC2030 framework is based on the principles of equity, quality, and financial risk protection. It emphasizes the importance of resilient and responsive health systems, and the need for a multi-sectoral approach to health.
See also[edit]
References[edit]
| Global health | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Global health related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian